跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS - HSA Drug Approval Details
Approvals
/
HSA
/
BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS
Approved
THERAPEUTIC
BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS
Fresenius Medical Care SMAD
🇸🇬 Health Sciences Authority
Approval Date
Jul 2, 2010
Approval ID
e9a331b4f54b516d
Company
Fresenius Medical Care SMAD
Type
Therapeutic
Approval Details
Approval Id
e9a331b4f54b516d
Drug Name
BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS
Product Name
BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS
Approval Number
SIN13822P
Approval Date
2010-07-02
Registrant
FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
Licence Holder
FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
POWDER, FOR SOLUTION
Route Of Administration
EXTRACORPOREAL
Pharma Manufacturer Name
FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
Company Detail Path
/organization/fresenius-medical-care-singapore-pte-ltd
Active Ingredients
Sodium Bicarbonate
100 %
SODIUM BICARBONATE
100%
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 2, 2010
Approval ID
e9a331b4f54b516d
Type
Therapeutic
Back to HSA Approvals
